Mario Sanchez
Family Medicine · Raymondville, TXNPI 1205804911
Payments from drug & device makers
Across 286 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$614
- Amarin Pharma, Inc.$411
- Boehringer Ingelheim$409
- Amgen$406
- AstraZeneca$385
- AbbVie$313
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,04593%
- Education$3207%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 59 | $614 |
| Amarin Pharma, Inc. | 18 | $411 |
| Boehringer Ingelheim | 14 | $409 |
| Amgen | 27 | $406 |
| AstraZeneca | 19 | $385 |
| AbbVie(2 entities) | 26 | $313 |
| Astellas Pharma US Inc | 13 | $282 |
| Pfizer | 25 | $279 |
| Lilly USA, LLC | 16 | $231 |
| Novartis | 16 | $184 |
| Johnson & Johnson | 11 | $146 |
| Merck | 8 | $130 |
| Genentech USA, Inc. | 5 | $91 |
| Vifor Pharma, Inc. | 5 | $86 |
| GSK | 3 | $62 |
| Abbott | 3 | $56 |
| Mylan Specialty L.p. | 3 | $51 |
| Radius Health, Inc. | 3 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Mannkind Corporation | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Bayer | 1 | $13 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
| Fidia Pharma USA Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,365 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 37 | $43,589 |
| MounjaroTirzepatide | 13 | $18,731 |
| FarxigaDapagliflozin Propanediol | 20 | $15,541 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 12 | $11,572 |
| VascepaIcosapent Ethyl | 17 | $9,763 |
| TradjentaLinagliptin | 12 | $9,208 |
| Rosuvastatin Calcium | 96 | $1,182 |
| Atorvastatin Calcium | 91 | $877 |
| Diclofenac Sodium | 17 | $858 |
| Losartan Potassium | 81 | $761 |
| Metformin Hcl | 84 | $651 |
| Metoprolol Succinate | 32 | $617 |
| Tamsulosin Hcl | 27 | $607 |
| Omeprazole | 50 | $575 |
| Pravastatin Sodium | 24 | $522 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $409 | $64,37061 claims |
| Lilly USA, LLCMounjaro | $231 | $18,73113 claims |
| AstraZenecaFarxiga | $385 | $15,54120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Raymondville
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.